Are circulating tumor cells an independent prognostic factor in patients with high-risk melanoma?
- 1 December 2004
- journal article
- Published by Springer Nature in Nature Clinical Practice Oncology
- Vol. 1 (2) , 74-75
- https://doi.org/10.1038/ncponc0041
Abstract
No abstract availableKeywords
This publication has 5 references indexed in Scilit:
- Molecular detection of circulating tumor cells is an independent prognostic factor in patients with high‐risk cutaneous melanomaInternational Journal of Cancer, 2004
- Quantitative Detection of Circulating Tumor Cells in Cutaneous and Ocular Melanoma and Quality Assessment by Real-Time Reverse Transcriptase-Polymerase Chain ReactionClinical Cancer Research, 2004
- Circulating DNA microsatellites: molecular determinants of response to biochemotherapy in patients with metastatic melanoma.JNCI Journal of the National Cancer Institute, 2004
- Molecular Tumor Markers in the Blood: Early Prediction of Disease Outcome in Melanoma Patients Treated With a Melanoma VaccineJournal of Clinical Oncology, 2003
- Detection of melanoma cells in peripheral blood by means of reverse transcriptase and polymerase chain reactionThe Lancet, 1991